Literature DB >> 8739237

Sympathetic control of cardiac myosin heavy chain gene expression.

M P Gupta1, M Gupta, E Dizon, R Zak.   

Abstract

Several neuroendocrine factors have been shown to influence the muscle phenotype. Various physiological reports have suggested the role of adrenergic nervous system for cardiac myosin heavy chain (MHC) expression. We have used cultured fetal rat heart myocytes to investigate the role of cAMP on the alpha- and beta-MHC gene expression. In low density cultures, addition of 1 mM 8 Br cAMP resulted in up regulation of alpha-MHC and down regulation of beta-MHC mRNA. This antithetic effect of cAMP depends on the basal expression of both expression of both MHC transcripts. In transient transfection analysis employing a series of alpha-MHC gene promoter/reporter constructs, we identified a 13 bp E-box M-CAT hybrid motif (EM element) which conferred a basal muscle specific and cAMP-inducible expression of the alpha-MHC gene. Data obtained from the mobility gel-shift analysis indicated that one of the factor(s) binding to the EM element is related to troponin T M-CAT binding factor (TEF-1). To test whether the protein binding to this sequence could be a substrate for cAMP-dependent phosphorylation, the cardiac nuclear proteins were preincubated in a kinase reaction buffer either with a catalytic subunit of PKA (CatPKA) or with cAMP, and binding activity of proteins to the EM element was evaluated by mobility gel shift assay. In a concentration dependent manner, a twofold increase in the intensity of the retarded band was observed. Furthermore, at 100 units of CatPKA, an additional band of faster mobility was observed which was not present either when phosphorylated nuclear extract was incubated with alkaline phosphatase or when ATP was absent in kinase reaction buffer. These results strongly suggest that factor(s) binding to the EM element is a substrate for cAMP dependent phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739237     DOI: 10.1007/bf00227889

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

1.  Myocardial activation of the human cardiac alpha-actin promoter by helix-loop-helix proteins.

Authors:  V Sartorelli; N A Hong; N H Bishopric; L Kedes
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  Thyroid hormone receptor alpha isoforms generated by alternative splicing differentially activate myosin HC gene transcription.

Authors:  S Izumo; V Mahdavi
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

Review 3.  Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles.

Authors:  B Swynghedauw
Journal:  Physiol Rev       Date:  1986-07       Impact factor: 37.312

4.  The ATPase activities of rat cardiac myosin isoenzymes.

Authors:  B Pope; J F Hoh; A Weeds
Journal:  FEBS Lett       Date:  1980-09-08       Impact factor: 4.124

5.  High-efficiency oligonucleotide-directed plasmid mutagenesis.

Authors:  D B Olsen; F Eckstein
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

6.  Expression of myosin isoenzymes in cardiac-muscle cells in culture.

Authors:  A C Nag; M Cheng
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

7.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

8.  Regulation of myosin isoenzyme composition in fetal and neonatal rat ventricle by endogenous thyroid hormones.

Authors:  R A Chizzonite; R Zak
Journal:  J Biol Chem       Date:  1984-10-25       Impact factor: 5.157

9.  Myocardial contractile function and myofibrillar adenosine triphosphatase activity in chemically sympathectomized rats.

Authors:  R T Dowell
Journal:  Circ Res       Date:  1976-11       Impact factor: 17.367

10.  Cyclic AMP regulation of myosin isozymes in mammalian cardiac muscle.

Authors:  S Winegrad; G McClellan; M Tucker; L E Lin
Journal:  J Gen Physiol       Date:  1983-05       Impact factor: 4.086

View more
  4 in total

Review 1.  Control of cardiomyocyte gene expression as drug target.

Authors:  H Rupp; M Benkel; B Maisch
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

2.  Cardiac myosin phenotype remodeling following chronic spinal transection.

Authors:  H A Kluess; A G Nelson; M A Duke
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

Review 3.  An evolutionary, structural and functional overview of the mammalian TEAD1 and TEAD2 transcription factors.

Authors:  André Landin-Malt; Ataaillah Benhaddou; Alain Zider; Domenico Flagiello
Journal:  Gene       Date:  2016-07-14       Impact factor: 3.688

4.  Temporal analysis of mRNA and miRNA expression in transgenic mice overexpressing Arg- and Gly389 polymorphic variants of the β1-adrenergic receptor.

Authors:  Karen Dockstader; Karin Nunley; Anis Karimpour-Fard; Allen Medway; Penny Nelson; J David Port; Stephen B Liggett; Michael R Bristow; Carmen C Sucharov
Journal:  Physiol Genomics       Date:  2011-09-27       Impact factor: 3.107

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.